Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk.

Cochrane database of systematic reviews (Online)

Volumn , Issue 4, 2005, Pages

  Franklin, J G ^a   Paus, M D ^a   Pluetschow, A ^a   Specht, L ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HODGKIN DISEASE; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SECOND CANCER;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HODGKIN DISEASE; HUMANS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT;

EID: 33644875971     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (127)